Reuters logo
BRIEF-Genentech says Fda approves its Actemra for treating CAR T cell-induced CRS
2017年8月30日 / 下午3点40分 / 1 个月前

BRIEF-Genentech says Fda approves its Actemra for treating CAR T cell-induced CRS

Aug 30 (Reuters) - Genentech:

* FDA approves Genentech’s Actemra (tocilizumab) for the treatment of CAR T cell-induced cytokine release syndrome Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below